SEIR Mathematical Model of Convalescent Plasma Transfusion to Reduce COVID-19 Disease Transmission
In some diseases, due to the restrictive availability of vaccines on the market (e.g., during the early emergence of a new disease that may cause a pandemic such as COVID-19), the use of plasma transfusion is among the available options for handling such a disease. In this study, we developed an SEI...
Guardado en:
Autores principales: | Hennie Husniah, Ruhanda Ruhanda, Asep K. Supriatna, Md. H. A. Biswas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/662fe03fac63470a9363da3a07db45a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini M, et al.
Publicado: (2021) -
Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series
por: Theresia Monica Rahardjo, et al.
Publicado: (2021) -
Convalescent plasma therapy in patients with coronavirus disease-19 – One year after: A brief review
por: Mariela Irabien-Zúñiga, et al.
Publicado: (2021) -
Convalescent plasma therapy in an immunocompromised patient with multiple COVID‐19 flares: a case report
por: Frini Karaolidou, et al.
Publicado: (2021) -
Sustained expression of inflammatory monocytes and activated T cells in COVID‐19 patients and recovered convalescent plasma donors
por: Ravinder Singh, et al.
Publicado: (2021)